Matt Zuga, Director at TELA Bio, Inc. (TELA), bought 303,937 shares at $13.00 ($1.1M) on 2019-11-08, disclosed to the SEC on 2019-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 10,220 | $133K | 11.9% |
| 2 | $13.00 | 75,901 | $987K | 88.1% |
| 3 | $0.00 | 217,816 | $0 | 0.0% |
| Total | $3.68 avg | 303,937 | $1.1M | 100% |
| Filing → |
| ABOS | SELL | 2026-01-07 | $59K | — | Filing → |
| ABOS | SELL | 2025-01-23 | $57K | — | Filing → |
| ABOS | SELL | 2025-01-07 | $24K | — | Filing → |